Enlivex (FRA:1BT) Short Interest


FRA:1BT Enlivex Ltd FRA:1BT
37 GF Score
Price €0.49
! 2 Warning Signs
View Full Analysis

What is Enlivex Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:1BT vs CNTB, SMNR, MENS: Short Interest Comparison

For the Biotechnology subindustry, Enlivex's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enlivex Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enlivex's Short Interest distribution charts can be found below:

* The bar in red indicates where Enlivex's Short Interest falls into.


FRA:1BT
37GF Score
Enlivex Ltd FRA:1BT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enlivex Business Description

Other Exchanges ENLV:USA
Address 14 Einstein Street, Weizmann Science Park, Ness Ziona, ISR, 7403618
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
37GF Score

Get the complete analysis for FRA:1BT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.49
Price